64Cu-SAR-BBN(Clarity Pharmaceuticals)

N/A

Report date: 2025/11/20 11:38:09

NME

Base Information

Drug Name64Cu-SAR-BBN(Clarity Pharmaceuticals)

Drug Alias NameCopper-labeled MeCOSar-PEG4-Bombesin(Clarity Pharmaceuticals)64Cu-SAR-Bombesin64Cu-labelled SAR-Bombesin

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionGastrin releasing peptide receptor antagonists

TargetsGastrin releasing peptide receptor

Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesClarity Pharmaceuticals Ltd

China Registration ClassN/A

Develop Information

Active CompaniesClarity Pharmaceuticals Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsProstatic Neoplasms, Castration-Resistant

Other Information

ATC CodeN/A